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Abstract
The translocated actin recruiting phosphoprotein (Tarp) is conserved among all pathogenic chlamydial species. Previous
reports identified single C. trachomatis Tarp actin binding and proline rich domains required for Tarp mediated actin
nucleation. A peptide antiserum specific for the Tarp actin binding domain was generated and inhibited actin
polymerization in vitro and C. trachomatis entry in vivo, indicating an essential role for Tarp in chlamydial pathogenesis.
Sequence analysis of Tarp orthologs from additional chlamydial species and C. trachomatis serovars indicated multiple
putative actin binding sites. In order to determine whether the identified actin binding domains are functionally conserved,
GST-Tarp fusions from multiple chlamydial species were examined for their ability to bind and nucleate actin. Chlamydial
Tarps harbored variable numbers of actin binding sites and promoted actin nucleation as determined by in vitro
polymerization assays. Our findings indicate that Tarp mediated actin binding and nucleation is a conserved feature among
diverse chlamydial species and this function plays a critical role in bacterial invasion of host cells.
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Introduction
The obligate intracellular gram negative bacterium, Chlamydia
trachomatis, is the most frequently reported sexually transmitted
disease in the United States and the leading cause of preventable
blindness worldwide [1]. This genetically intractable microor-
ganism undergoes a developmental cycle that involves an
extracellular infectious form referred to as an elementary body
(EB) and an intracellular replicative reticulate body (RB). EB to
RB and RB to EB transitions occur within the protective confines
of a membrane bound parasitophorous vacuole termed an
inclusion [2].
The exact mechanisms of chlamydial attachment and entry of
nonphagocytic cells are unclear, but certain features, such as the
recruitment of actin to the site of attachment, are conserved
among all chlamydial species examined thus far [3]. Further-
more, drugs such as cytochalasin D that prevent actin
polymerization inhibit infection [3–7]. Like many intracellular
microorganisms, chlamydial pathogenesis is partially mediated by
the translocation of secreted effectors at the time of bacterium-
host-cell contact [8–13]. Recent studies have shown that C.
trachomatis directly induces actin polymerization via the type III
secreted effector, Tarp [14]. C. trachomatis elementary bodies
harbor presynthesized Tarp effector protein which is tyrosine
phosphorylated upon translocation to the cytosol of the host cell
and has been implicated in the recruitment of actin observed at
the site of chlamydial attachment in vivo [9]. Tarp was
subsequently shown to polymerize actin independently of host
factors in vitro [14]. The mechanism of Tarp actin nucleation
appears to be distinct from known eukaryotic actin nucleators
[15]. Chlamydia trachomatis L2 Tarp harbors at least three
functionally distinct domains; an N-terminal tyrosine-rich repeat
domain of unknown function, a proline rich domain required for
Tarp oligomerization and a single Wiskott-Aldrich syndrome
protein (WASP)-Homology-2 (WH2) G-actin binding domain
[9,14]. The proline rich domain and actin binding domain are
harbored within the minimum Tarp peptide required for Tarp
mediated actin nucleation. Oligomerization mediated by the
proline-rich domain presumably brings multiple actin monomers
into apposition to nucleate actin filament formation [14].
Sequence analysis of all known Tarp orthologs indicate that the
proline rich domain and actin binding alpha helix are conserved
although the tyrosine-rich repeat domain is absent from C. caviae,
C. muridarum,a n dC. pneumoniae [16].
Overall, Tarp orthologs show a low level of sequence identity
[16], however the actin binding domains appears to be a conserved
feature. We demonstrate here that Tarp orthologs from Chlamydia
pneumonia, C. caviae, C. muridarum and various C. trachomatis serovars
all harbor at least one and up to four functional actin binding
domains and that purified recombinant Tarps from all chlamydial
species were capable of nucleating actin filament formation in vitro.
Furthermore, a peptide antiserum with affinity to the actin binding
domain prevented Tarp mediated actin nucleation and, when
delivered into host cells, significantly reduced host cell susceptibility
to chlamydial infection. Our findings show that Tarp mediated
actin polymerization is a conserved feature among diverse
chlamydial species and suggest that the actin binding domain plays
an important role in bacterial entry.
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A peptide antibody recognizes the actin binding domain
of C. trachomatis L2 Tarp
Three distinct domains of the C. trachomatis Tarp effector have
been described. These include: the tyrosine rich repeat region
(amino acids 125–424), a proline rich domain required for Tarp
multimerization (amino acids 625–650), and an actin binding
domain (amino acids 748–758) [9,14,16,17]. Only the proline rich
domain and actin binding domain appear to be conserved among
chlamydial species. To determine the significance of the actin
binding domain, an anti-peptide antibody to amino acids 746–760
encompassing that region was produced in rabbits and antigen-
affinity purified to generate the anti actin binding domain (ABD)
antibody. This antibody demonstrated affinity to the actin binding
domain as confirmed by immunoblots using a series of GST-L2-
Tarp fusion proteins (Figure 1A). Western blot analysis of
chlamydia-infected host cells with the ABD antibody confirmed
the antibody recognizes Tarp in the infected lysates but did not
detectably cross-react with any host proteins (Figure 1B). The
affinity purified L2 Tarp ABD antibody also recognized an
immunodominant protein in lysates generated from purified EBs
of other chlamydial species including C. pneumoniae, C. muridarum,
and C. caviae (Figure 1C).
Although the ABD antibody was produced against a 15 amino
acid peptide antigen, specificity was further examined under more
native conditions. C. trachomatis L2-infected and uninfected HeLa
cells were solubilized in RipA buffer and dot-immunoblotted
against the ABD antibody (Figure 1D). This antibody did not
detectably cross-react with any host proteins in the whole cell
lysate. To confirm this specificity, Tarp was immunoprecipitated
from these lysates and probed for WAVE2, which among
eukaryotic WH2-domain containing proteins, exhibits the closest
similarity to the WH2 domain of Tarp [17,28] (Figure 1E and F).
Again, no cross-reactivity with WAVE2 was observed. Despite our
inability to detect reactivity of the ABD antibody to WAVE2 by
immunoblotting, immunoprecipitation, or dot blot analysis, we
cannot rule out the possibility of low affinity antibody binding to
WH2 domains below detectable limits.
The actin binding domain antibody inhibits actin
nucleation in vitro and chlamydial invasion in vivo
To investigate whether the ABD antiserum would disrupt the
actin nucleating capabilities of Tarp, pyrene conjugated actin was
used to examine the kinetics of actin polymerization as previously
described [14]. Pre-incubation of purified L2 Tarp with ABD
antiserumcompletelyinhibitedTarp mediatedactinpolymerization
(Figure 2A). These data indicate that the ABD antiserum is capable
of neutralizing Tarp mediated actin polymerization in vitro.
The actin nucleating activity of the chlamydial Tarp effector
within the host cell is presumed to play an important role in
initiating actin polymerization at the site of EB attachment [9,14].
To define a role for the Tarp actin binding domain and
subsequent actin nucleation in vivo, affinity purified ABD
antiserum was delivered into the cytosol of host cells as described
in the Materials and Methods and the rate of EB invasion was
determined. Host cells pre-loaded with the ABD antibody were
significantly (P,0.0001) more resistant to EB invasion compared
to host cells containing control antisera or ABD serum neutralized
with the peptide immunogen (Figure 2B). These data suggest that
the actin nucleating activity of Tarp is required for C. trachomatis
invasion.
The Tarp actin binding domain is a conserved feature
among Tarp orthologs
All pathogenic chlamydial strains and serovars examined to date
harbor a Tarp effector. Interestingly, the overall protein sequence
of Tarp orthologs is quite divergent between chlamydial species
[9,16,18–22]. However, the Tarp actin binding domain is present
in all examined strains (Figure 3A). Sequence analysis indicates
that each Tarp ortholog contains between 1 and 4 putative actin
binding domains (Figure 3B). As previously reported, C. trachomatis
L2 Tarp mediated actin nucleation is localized to a 200 amino
acid domain encompassing the actin binding domain (ABD) and
the upstream proline-rich domain (PRD) [14]. In order to
determine if the putative actin binding domains present in the
Tarp orthologs are functional, GST-Tarp fusions were generated
for each of the predicted ABDs from C. caviae, C. pneumoniae, C.
trachomatis serovar L2 C. trachomatis serovar D, C. trachomatis serovar
A, and C. muridarum. Tarp actin binding domains were expressed
individually, purified, and tested for their ability to precipitate host
cell actin from soluble HeLa extracts (Figure 3C). All chlamydial
Tarps contain at least one functional actin binding domain as
determined by in vitro pulldown assays. Interestingly, in those C.
trachomatis strains possessing multiple predicted ABDs, the most C-
terminal predicted ABD in those Tarp orthologs was least similar
in sequence to the functional ABDs and failed to precipitate actin
in pull-down assays. C. trachomatis serovars D and A, C. muridarum
and C. caviae harbor multiple functional actin binding domains
whereas C. trachomatis L2 and C. pneumoniae harbor only a single
functional ABD. These data demonstrate that all chlamydial
Tarps are capable of binding actin and have the potential to
influence host actin kinetics following translocation into host cells.
Tarp orthologs demonstrate enhanced actin
polymerization kinetics
To determine if the Tarp orthologs were capable of
manipulating the rate of actin polymerization in vitro, pyrene
Author Summary
Chlamydiae are bacterial obligate intracellular pathogens
responsible for multiple human and veterinary diseases.
The induction of cytoskeletal rearrangements to promote
chlamydial internalization is partially mediated by a type III
secreted effector protein called Tarp that is translocated
upon contact with host cells and independently nucleates
actin filament formation. Tarp from a C. trachomatis
lymphogranuloma venereum (LGV) strain consists of a
tyrosine-rich repeat domain, a proline-rich domain re-
quired for oligomerization, and a single actin binding
domain. Oligomerization is required to bring multiple actin
monomers together to initiate actin filament formation by
a mechanism distinct from host actin nucleators. Here we
have examined Tarp from several other strains of
chlamydiae and find that certain of these contain up to
four actin binding domains. Tarp fragments bearing
multiple actin binding domains nucleate actin in in vitro
assays even in the absence of the oligomerization domain.
This suggests that Tarp from different chlamydial species
may utilize hybrid mechanisms to induce actin nucleation.
Determination of virulence determinants in chlamydiae is
challenging due to the lack of tractable genetic systems.
The direct introduction of anti-Tarp actin binding domain
antibodies into the cytosol of host cells inhibited entry and
thus demonstrates an essential role for Tarp in chlamydial
pathogenesis.
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PLoS Pathogens | www.plospathogens.org 3 July 2010 | Volume 6 | Issue 7 | e1000997Figure 1. The Tarp actin binding domain (ABD) peptide antibody recognizes native Tarp of multiple serovars and species and does
not recognize the ABD of the host cell WAVE2 protein. A) Schematic of C. trachomatis GST-Tarp fusions used to examine the specificity of the
peptide antibody directed toward the Tarp actin binding domain. Tarp amino acids and positions are indicated above each bar in the schematic.
Purified GST fusions were immobilized to nitrocellulose and immunoblots were performed with Tarp actin binding domain (aABD) and Tarp (a Tarp)
specific antibodies. B) The Tarp actin binding domain (a ABD) specific antisera recognizes only a single protein within chlamydia-infected host cells.
Chlamydia-infected (+L2) and uninfected (2L2) host cells were suspended in protein sample buffer following a 30 min. infection. Proteins were
resolved by SDS-PAGE and visualized by Coomassie blue staining (CB). Immunoblots were performed with Tarp (a Tarp) and Tarp actin binding
domain (a ABD) specific antisera. C) The Tarp actin binding domain (a ABD) antibody recognizes a protein in lysates generated from purified C.
trachomatis serovar L2 (LGV-434), C. caviae (GPIC), C. pneumoniae (Cpn), C. trachomatis serovar D (D-UW3), C. trachomatis serovar A (A HAR-13) and C.
muridarum mouse pneumonitis biovar (MoPn) elementary bodies. Loading for SDS-PAGE was based upon equivalent numbers of EBs. C. pneumoniae
Tarp was not readily visible on the original exposure but was easily visualized with longer exposures. D) The Tarp actin binding domain (a ABD)
antibody recognizes non-reduced, non-denatured native protein immobilized to nitrocellulose. Immunoblots were performed of lysates generated
from cells infected with C. trachomatis (HeLa +L2) and uninfected host cells (HeLa). Purified recombinant Tarp protein (C-domain Tarp) and solubilized
lysates derived from elementary bodies (EBs) served as positive controls. Immunoblots to detect WAVE2 (a WAVE2) and actin (a actin) were
performed as additional controls. E) The Tarp actin binding domain (a ABD) antibody immunoprecipitates Tarp from infected cells. Tarp was
immunoprecipitated with a ABD from lysates generated from cells infected with C. trachomatis (HeLa +L2) and uninfected host cells (HeLa). Proteins
were resolved by SDS-PAGE and immunoblotted with Tarp (a Tarp) and WAVE2 (a WAVE2) specific antibodies (arrowheads). The anti-Tarp polyclonal
antibody recognizes an unknown antigen in the infected and uninfected HeLa cell lysates that is not immunoprecipitated by the a ABD antibody. The
aABD antibody does not recognize this antigen in immunoblots (panels B, D, and F). Note that the IgG heavy chain is observed in both infected and
uninfected lanes. F) Tarp and WAVE2 were immunoprecipitated from infected (+L2) and uninfected (2L2) HeLa cells, resolved by SDS-PAGE and
immunoblotted with Tarp actin binding domain (a ABD) and WAVE2 (a WAVE2) specific antibodies (arrowheads). Molecular mass is in kilodaltons
(kDa) for panels B, C, E & F.
doi:10.1371/journal.ppat.1000997.g001
Figure 2. The Tarp actin binding domain (ABD) peptide antibody inhibits Tarp mediated actin polymerization in vitro and inhibits
chlamydial entry in vivo.A ) Tarp mediated actin nucleation (Tarp) was inhibited by the addition of Tarp actin binding domain specific antisera
(Tarp+ABD Ab). Purified Tarp, GST and antibodies were added to 1mM pyrene conjugated actin and actin polymerization was measured as arbitrary
fluorescence intensity (Intensity a.u.) over time (Time seconds) following the addition of polymerization buffer at 300 seconds. An irrelevant antibody
did not alter Tarp (Tarp+control Ab) or GST (GST+control Ab) mediated actin polymerization. GST (GST) and actin alone (actin alone) served as
additional controls. B) Graphical representation of EB invasion of ABD antibody pre-loaded HeLa cells. HeLa cells were pre-loaded with ABD or
nonspecific control antibodies (control Ab) using a cationic lipid mixture (Pro-Ject Protein Transfection Reagent) to deliver the antibodies to the host
cytosol. Intrinsically fluorescent CMPTX labeled EBs were used in invasion assays. After allowing for 30 min invasion, extracellular EBs were
counterstained by indirect immunofluorescence with a monoclonal antibody to C. trachomatis L2 MOMP and a goat anti mouse antibody conjugated
to Alexa 488. The percent of EB invasion (% invasion) was determined for cells harboring purified ABD (ABD Ab), ABD preincubated with an excess of
the peptide immunogen (ABD Ab+peptide) and irrelevant control antibody (control Ab). Additional controls included untreated host cells (No Ab).
The results are from one experiment representative of three separate experiments.
doi:10.1371/journal.ppat.1000997.g002
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harboring sequences similar to the minimal 200 amino acid
polymerization domain of C. trachomatis L2 (i.e. containing the
proline-rich and actin binding domains) were tested for enhanced
actin polymerization compared to GST and actin alone controls.
The C. trachomatis serovars D, A and MoPn Tarp orthologs
increased the rate of actin polymerization to levels comparable to
L2 (Figure 4A). Likewise, GST-Tarp fusions of C. caviae and C.
pneumoniae increased the rate of actin polymerization compared to
controls although not to the same degree as L2 (Figure 4B,C).
These data demonstrate that all chlamydial Tarps examined
promoted actin polymerization in vitro suggesting that all
chlamydial species and serovars directly manipulate host
cytoskeletal dynamics. Actin nucleation requires alignment of
actin monomers to initiate the formation of an actin filament.
The 200 amino acid L2 Tarp fragment required for actin
nucleation contains only a single actin binding domain and
therefore necessitates oligomerization of the L2 Tarp peptide to
nucleate actin. The proline rich domain is believed to be
responsible for L2 Tarp oligomerization [14]. To determine if the
Tarp orthologs which contain multiple actin binding sites are
capable of actin nucleation in the absence of the proline-rich
Figure 3. Tarp orthologs harbor multiple actin binding domains. A) A schematic of the Tarp orthologs from C. trachomatis serovar L2 (L2), C.
trachomatis serovar D (D), C. trachomatis serovar A (A), C. muridarum (MoPn), C. pneumoniae (Cpn), and C. caviae (GPIC) indicating the location of the
putative actin binding domains (red boxes), a proline rich domain (blue boxes), and tyrosine rich phosphorylation domain (green boxes). B) ClustalW
sequence alignment of the putative actin binding domains from Tarp orthologs in A. The sequence predicted to harbor the actin binding alpha helix
is indicated by the open box. Identical amino acids within each alignment are in red. Similar residues are in blue. The consensus sequence shown is
based on homology greater than 50%. The number indicates the amino acid residue of the amino terminus of the peptide shown. C) The Tarp
orthologs associate with actin. GST-fusions of the Tarp orthologs described above harboring sequence similar to the C. trachomatis L2 (L2) actin
binding domain were expressed and purified. Extracts from HeLa cells were incubated with GST or GST fusions to Tarp orthologs and specifically
bound proteins were resolved by SDS-PAGE and visualized by Coomassie blue staining (CB). Samples identical to those shown in the Coomassie-
stained gel were subject to immunoblotting with an actin (a actin) specific antibody. A GST fusion to the VCA domain of N-wasp (GST-VCA) served as
a positive control for actin binding.
doi:10.1371/journal.ppat.1000997.g003
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PLoS Pathogens | www.plospathogens.org 5 July 2010 | Volume 6 | Issue 7 | e1000997Figure 4. C. caviae, C. pneumoniae and C. trachomatis Tarp orthologs promote actin polymerization. A) Pyrene actin polymerization in the
presence of GST-Tarp fusions. GST-Tarp fusions representing the C-domain of C. trachomatis L2 (L2), C. trachomatis serovar D (D) C. trachomatis A
HAR13 (A) and C. muridarum (MoPn) were incubated with 1mM pyrene conjugated actin and actin polymerization was measured as arbitrary
fluorescence intensity (Intensity a.u.) over time (Time seconds) following the addition of polymerization buffer at 300 seconds. GST and actin alone
served as negative controls. B) Pyrene actin polymerization assays as A but with GST-Tarp fusions of the C-domain of C. caviae (GPIC), C. trachomatis
L2 (L2), and negative controls GST, and actin alone. C) Pyrene actin polymerization assays as A but with GST-Tarp fusions of C. pneumoniae (CPn), C.
trachomatis L2 (L2), and negative controls GST, and actin alone. D) Pyrene actin polymerization assays as A but with GST-Tarp fusions of Tarp
orthologs lacking the proline rich domain. Note that all Tarp orthologs with greater than one actin binding domain increase initial rates of actin
polymerization over the GST control. As previously shown [14], C. trachomatis L2 Tarp lacking the proline rich domain sequesters actin monomers to
depress actin nucleation rates below control levels. The results are from one experiment representative of three separate experiments.
doi:10.1371/journal.ppat.1000997.g004
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rich domain and tested for their ability to nucleate actin. All Tarp
orthologs which contain multiple actin binding sites were able to
nucleate actin despite removal of their respective proline-rich
domains (Figure 4D). These data suggest that while all Tarp
orthologs are capable of actin nucleation, they may employ
unique mechanisms of actin nucleation.
Oligomerization of Tarp with multiple ABDs is not
required for actin nucleation
C. trachomatis L2 Tarp, which contains only a single actin
binding site, must oligomerize to catalyze actin nucleation [14].
Because the Spire protein of Drosophila, which contains four actin
binding WH2 domains on a single polypeptide, has been reported
to function independently as an actin nucleator [24], we
examined the ability of Tarp fragments from C. trachomatis
serovar A, whose Tarp protein harbors three functional ABDs, to
nucleate actin filament formation in in vitro pyrene-actin
fluorescence assays (Figure 5). Serovar A Tarp fragments bearing
only the three ABDs or the three ABDs plus the proline-rich
oligomerization domain were expressed as GST fusions, purified,
and the GST domain cleaved from the Tarp (Figure 5A). Serovar
A Tarp fragments bearing only the ABDs or the PRD plus the
ABDs were applied to gel filtration sizing columns and fractions
collected for analysis of Tarp fragment presence by dot
immunoblot as previously described for serovar L2 Tarp domain
analysis [14] (Figure 5B). Similar to L2 Tarp, serovar A Tarp
fragments containing the proline-rich domain formed large
oligomeric complexes while fragments containing only the ABDs
did not (Figure 5B). However, in contrast to L2 Tarp fragments
[14], both the fragments containing ABDs alone and the
fragments containing the ABDs plus the PRD nucleated actin
filament formation in pyrene-actin assays (Figure 5C). C.
trachomatis A Tarp therefore appears to have the potential to
utilize a hybrid mechanism involving actin nucleation by the
alignment of at least three actin monomers on a linear
polypeptide as well as actin polymerization by oligomerization
of the Tarp protein due to the presence of the proline-rich
oligomerization domain which is indispensible for those Tarp
orthologs harboring only a single ABD.
Figure 5. The C. trachomatis serovar A Tarp ortholog employs a spire-like actin nucleation mechanism and does not require the L2
Tarp proline rich domain for actin nucleation. C. trachomatis serovar A Tarp fragments harboring either the three functional actin binding
domains (ABDs) alone or the actin binding domains and the proline rich domain (PRD) were digested to remove the GST moiety and analyzed by gel
filtration and pyrene actin polymerization assays. A) C. trachomatis serovar A GST-Tarp fusion proteins were purified and digested with protease (+/2
enz) to remove the GST moiety (* indicates GST is removed). Proteins were resolved by SDS/PAGE and visualized by Coomassie blue staining. B)
Removal of the proline rich domain from C. trachomatis A Tarp inhibits oligomerization. Gel filtration of proteins shown in panel A. Protein fractions
were collected in 2-min intervals from gel filtration columns and immobilized to a nitrocellulose membrane by vacuum filtration. Membranes were
subjected to immunoblotting with a Tarp specific antibody. Protein standards are indicated above the dot-blot with respective molecular weight and
peak elution times. C) Oligomerization of C. trachomatis A Tarp is not required for actin nucleation. Purified Tarp (A) with and without proline rich
domain increased actin polymerization compared to GST and actin alone controls in pyrene actin polymerization assays. The results are from one
experiment representative of three separate experiments.
doi:10.1371/journal.ppat.1000997.g005
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Many bacterial pathogens modulate actin dynamics of eukary-
otic host cells as a virulence mechanism. These pathogenic
processes may involve manipulation of the cytoskeleton to
promote internalization, inhibition of actin polymerization to
prevent phagocytosis, or utilization of actin filamentation to
promote intracellular movement and cell-to-cell spread of cytosolic
pathogens. In most cases, bacteria that stimulate actin filament
formation directly or indirectly do so through the recruitment of
host actin nucleating machinery [25]. Recently, it has been
recognized that certain bacterial proteins display actin nucleating
activity independently of host factors [14,15,26–28]. The mech-
anism of chlamydial Tarp actin nucleation appears to be distinct
from known eukaryotic or bacterial actin nucleators [14]. C.
trachomatis L2 Tarp contains a single WH2 actin binding domain
and requires an upstream proline-rich domain for oligomerization,
which presumably brings multiple actin monomers into apposition
to nucleate actin filament formation [14]. Surprisingly, Tarp of
some chlamydial strains and species contains multiple actin
binding domains on a single polypeptide thus may utilize a hybrid
mechanism of actin nucleation involving binding of multiple actin
monomers to a single polypeptide but potentially synergistic with
oligomerization mediated by the upstream proline-rich domain.
Notably, the actin binding function of Tarp appears to be essential
to chlamydial pathogenesis as inhibition of its activity by cytosolic
anti-ABD antibody is inhibitory to internalization of EBs.
Factors that nucleate actin filament formation do so through the
stabilization of at least three actin monomers to overcome the
kinetic barrier to nucleation. Eukaryotic cells possess three general
classes of actin nucleation factors; the Arp2/3 complex, formins,
and Spire [29,30]. Each of these initiates actin filament formation
by distinct mechanisms. The Arp2/3 complex nucleates branched
filaments from existing actin filaments [31]. This is in contrast to
Tarp, which nucleates linear filaments [14]. Formins nucleate
formation of linear actin filaments and possess two characteristic
formin homology domains, FH1 and FH2 [32,33], which are not
found in Tarp. The Spire protein of Drosophila also nucleates
formation of linear actin filaments but does so through a
mechanism involving four sequential WH2 domains on a single
peptide [24]. More recently, it has been shown that Spire functions
in close association with the Drosophila formin, Cappuccino [34].
As additional eukaryotic and bacterial proteins with actin
nucleating activity have been discovered, it has become apparent
that many of these novel nucleators do not fall clearly into of the
above classes but may possess a combination of functional domains
to create an actin nucleator employing hybrid mechanisms of actin
nucleation [15]. For example, Cordon-Bleu, a vertebrate-specific
nucleator important in neuronal development, contains three
WH2 domains and six proline-rich domains [35]. Leiomodin-2,
another recently recognized nucleator found in heart and skeletal
muscle, is characterized by an N-terminal actin binding helix
similar to that of tropomodulins, a leucine-rich repeat domain that
binds actin, and a C-terminal WH2 domain [36]. Bacterial
proteins with actin nucleating activity include Salmonella SipC [26],
Vibrio VopF [28], and VopL [27], and chlamydial Tarp [14].
Although the mechanisms of actin nucleation differ, all but SipC
share a common theme of the presence of one or more WASP
Homology 2 (WH2) actin binding domains [15]. VopF and VopL
each contain three WH2 domains and two proline-rich domains
with the most N-terminal of these showing similarity to formin
homology domain 1 (FH1) [27,28]. Chlamydial Tarp shows no
homology to formins but, as we demonstrate here, possesses a
variable number of WH2 domains.
Comparison of the sequenced Tarp orthologs reveals a
surprising diversity of isomers. C. trachomatis L2 Tarp contains six
tyrosine-rich repeats while serovars D and A contain only three
[9,18],. Chlamydia pneumoniae, C. caviae, C. muridarum Tarp proteins
lack the tyrosine-rich repeat domain and are not tyrosine
phosphorylated [16]. Sequence analysis of all known Tarp
orthologs indicates that the proline rich domain and actin binding
alpha helix are conserved [16]. However, some Tarp orthologs
harbor multiple actin binding domains. All Tarp orthologs
examined harbored at least one actin binding domain that
associated with actin derived from HeLa cell extracts. Further-
more, all Tarp orthologs increased initial rates of actin
polymerization in vitro compared to actin alone and GST controls.
Surprisingly, the C. caviae and C. trachomatis serovars A and D Tarp
orthologs contained multiple functional actin binding domains
suggesting a spire-like actin nucleation mechanism involving
multiple WH2 domains on a single peptide may be employed by
some Tarp orthologs. The presence of multiple ABDs could
potentially allow one Tarp protein to align multiple actin
monomers together to initiate an actin filament. While Tarp
fragments harboring multiple actin binding domains nucleated
actin in vitro even in the absence of the proline rich oligomerization
domain, this domain appears to be conserved thus the proline-rich
domain likely plays an essential role in promoting actin nucleation
in vivo.. The biological advantage to strains bearing different
numbers of Tarp WH2 domains is unclear. Indeed, the extent of
variation within known C. trachomatis serovars or between clinical
isolates is unknown. Intrinsic differences in Tarp structure are
perhaps not surprising given that chlamydiae differ both clinically
and biologically, demonstrating diverse tissue tropisms and varying
degrees of localized and systemic infection [1,37].
To confirm the role of the Tarp effector in vivo, an antibody was
raised to a peptide overlapping the C. trachomatis L2 Tarp WH2
actin binding domain.. Antibody specific for the Tarp actin
binding domain completely neutralized Tarp mediated actin
nucleation in vitro. Furthermore, delivery of the ABD serum into
host cells prior to a chlamydial infection significantly reduced the
number of invasive bacteria. These data suggest that intracellular
ABD antibody is capable of neutralizing the Tarp actin nucleating
activity following translocation into the host but prior to bacterial
entry. Defining essential virulence determinants in pathogens like
chlamydiae that lack tractable genetic systems is often difficult.
The inhibition of entry by intracellular antibody to a functional
domain implies a role for Tarp as a virulence determinant of
chlamydiae.
In addition to Tarp, chlamydial entry is also dependent on
signal transduction cascades initiated following activation of host
Rho family GTPases culminating in the activation of host cell
Arp2/3 complex [38–41]. Because host cell Arp2/3 complex is
also required for C. trachomatis invasion, we have proposed that the
chlamydial and cellular actin nucleating activities function in
concert to promote chlamydial invasion [14,40]. Tarp nucleates
the formation of linear actin filaments [14], whereas host Arp2/3
nucleates actin filaments that grow from the side of existing linear
filaments, thus the two mechanisms may function synergistically.
Although the role of phosphorylated Tarp in entry and the
recruitment of Arp2/3 is somewhat controversial [16,17,42–44],
Tarp proteins secreted from C. pneumoniae and C. caviae are not
phosphorylated and therefore presumably either do not activate
the Arp2/3 complex or activate Arp2/3 by an alternate signaling
pathway. Furthermore, inhibition of C. trachomatis L2 Tarp
tyrosine phosphorylation had no adverse effect on entry [17].
The signaling cascades initiated by the different chlamydiae
appear to be species specific. C. trachomatis invasion requires the
The ABDs of Chlamydial Tarps
PLoS Pathogens | www.plospathogens.org 8 July 2010 | Volume 6 | Issue 7 | e1000997Rac GTPase while C. caviae requires both Rac and Cdc42 [39,41].
Potentially related to the biodiversity exhibited by various
chlamydial species, Tarp orthologs harbor domains that are
species specific but variable in number such as the tyrosine rich
repeat domain and conserved domains like the actin binding alpha
helical domain that also varies in number [16]. Despite the
observed differences in phosphorylation of the tyrosine rich repeat
domain, the actin binding domain identified in all Tarp orthologs
examined is conserved and a testament to the significance of this
domain in chlamydial biology.
The Tarp effectors from various chlamydial species harbor
distinct and conserved features such as the tyrosine rich repeat
domain and the actin binding domain, respectively. In this study
we demonstrate that all Tarp orthologs examined share the ability
to bind and nucleate actin directly. This conserved feature is
required for efficient invasion of host cells. Further elucidation of
how Tarp and the Arp2/3 complex cooperate to produce a
successful invasion is required to fully characterize the chlamydial
entry mechanism. Careful analysis of the unique features of
various Tarp orthologs may provide insight into differences
observed within chlamydial species regarding tissue tropism and
dissemination. Taken together our findings suggest that the type
III secreted effector protein Tarp plays a vital role in chlamydial
entry of human cells.
Materials and Methods
Organisms and cell culture
Chlamydia trachomatis serovar L2 (LGV 434), serovar D (UW-3-
Cx), serovar A (HAR-13), C. muridarum, C. caviae, and C. pneumoniae
(CWL029) were propagated in HeLa 229 cells and purified by
Renografin density gradient centrifugation [45].
Cloning, protein expression and purification
DNA fragments encoding the putative actin binding domain(s)
of the Tarp orthologs from C. pneumoniae CWL029 (CPn0572)
(Gly
440-Val
540), (Met
1-Lys
755), C. caviae (CCA00170) (Leu
460-
Asn
560), (Lys
540-Ser
640), (Ser
640-Pro
740), (Thr
366-Gln
666), (Leu
460-
Pro
740), C. muridarum (TC0741) (Glu
500-Asp
600), (Thr
620-Asp
720),
(Asp
720-Gly
820), (Asn
840-Glu
940), (Ser
400-Ala
827), (Glu
500-Glu
940),
C. trachomatis biovar A HAR-13 (CT456) (Asp
580-Thr
680), (Pro
700-
Ala
800), (Ala
820-Val
920), (Thr
940-Asp
1040),(Ser
489-Ser
926),(Asp
580-
Val
920); biovar D UW-3-Cx (CT456) (Ser
600-Glu
700), (Glu
700-
Gln
820), (Gln
820-Lys
940), (Ser
503-Ser
825), (Ser
600-Lys
940); and biovar
L2 LGV 434 (CT456) (Asp
726-Ser
825), (Pro
826-Lys
940), (Ser
625-
Ser
825),(Thr
425-Ser
825), (Asp
726-Lys
940) were generated by PCR. In
frame glutathione-S-transferase (GST) fusion proteins were
generated by PCR amplifying the corresponding coding regions
from Chlamydiae genomic DNA (Qiagen genomic purification kit,
Valencia CA) using custom synthesized oligonucleotide primers
(Integrated DNA Technologies, Coralville, IA) engineered with
BamHI, EcoRI or XhoI linkers. PCR products were purified
(Qiagen), digested with restriction enzymes (New England Biolabs,
Beverly, MA) and subcloned into linearized pGEX-6P-1 to
generate translational fusions with GST at the C-terminus.
pGEX-6P-1 plasmids encoding the Tarp orthologs were
transformed into BL21 strain of E. coli (Novagen, Madison WI).
Protein expression and purification were performed according to
the procedures outlined in the Bulk GST Purification Module (GE
Health Sciences, Piscataway, NY).
GST fusion pull-down experiments
HeLa 229 cells were suspended in 100mM KCl, 10mM HEPES
(pH 7.7), 2mM MgCl2 and 2mM ATP (buffer A) and disrupted by
sonication delivered in four consecutive bursts of 20 second
intervals on setting #4 (Ultrasonic Sonicator Processor XL
equipped with a microtip: Misonix Incorporated, Farmingdale,
NY). Insoluble material was removed by centrifugation
(12,000 rcf, 25 min., 4uC). Glutathione-sepharose beads were
incubated with 10mg of GST fusion proteins or GST for 1 hour at
4uC in PBS. (GE Health Sciences). GST-fusion protein coated
beads were washed twice with PBS and once with buffer A prior to
the addition of approximately 100mg of HeLa extract. Extracts and
beads were incubated together for 2 hours at 4uC, washed three
times with fresh buffer A and bound proteins were eluted using
sample buffer.
SDS-PAGE, immunoblotting and antibodies
Proteins were separated on SDS-10% polyacrylamide gels and
transferred to 0.45mm pure nitrocellulose transfer and immobili-
zation membrane (Schleicher & Schuell, Keene, NH). Immuno-
blotting employed peroxidase conjugated secondary antibodies
(Chemicon International, Temecula, CA) and Supersignal West
Pico chemiluminescent substrate (Pierce, Rockford, IL). The anti-
actin C4 monoclonal antibody was purchased from Chemicon
International. Polyclonal rabbit antibodies directed towards C.
trachomatis L2 LGV 434 Tarp (CT456) was developed at Rocky
Mountain Laboratories as previously described [9]. Rabbit
antibodies directed toward the Tarp actin binding domain were
generated against the peptide sequence GPAMKDILSAVRKHL
and antigen-affinity purified by Sigma Genosys (Spring, TX).
Immunoprecipitation
Fifty ml of mouse anti- WAVE2 (L-32) (Santa Cruz Biotechnol-
ogy, Santa Cruz, CA) or mouse anti-Tarp (F07G2) was added to
50 ml of premixed protein A and G coated sepharose fast flow
beads in 500 ml of PBS (GE Healthcare Bio-Sciences AB,
Piscataway, NJ). Following a 1 hour incubation at 4uC, antibody
coated beads were washed with fresh PBS. 1610
7 HeLa control
cells and 1610
7 HeLa cells infected with C. trachomatis L2 were
solubilized in RIPA buffer (150 mM NaCl, 1.0% IGEPAL CA-
630, 0.5% sodium deoxycholate, 0.1% SDS, and 50 mM Tris,
pH 8.0). Insoluble material was removed by microcentrifugation
(15,000 rcf, 10 minutes, 4uC). Soluble lysate was added to the
washed beads and incubated at 4uC for 3 hours. Beads were
washed four times with RIPA buffer and the protein coated beads
were suspended in 100 ml of protein sample buffer. Precipitated
proteins were resolved on SDS PAGE and transferred to
nitrocellulose membranes for immunoblotting with antibodies
specific for the Tarp actin binding domain or WAVE2 (Chemicon,
Temecula, CA)
Dot blots
1610
7 HeLa control cells, 1610
7 HeLa cells infected with C.
trachomatis L2, purified C. trachomatis L2 elementary bodies and
recombinant Tarp protein were solubilized in RIPA buffer
(150 mM NaCl, 1.0% IGEPAL CA-630, 0.5% sodium deoxycho-
late, 0.1% SDS, and 50 mM Tris, pH 8.0). Insoluble material was
removed by microcentrifugation (15,000 rcf, 10 minutes, 4uC).
Equal volume of soluble material was placed onto nitrocellulose
membranes and immunoblotting was performed with antibodies
specific for Tarp, the Tarp actin binding domain, WAVE2 or
actin.
Pyrene assay
The rate of actin polymerization in the presence of GST-fusions
was monitored according to the methods outlined in the Actin
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Briefly, monomeric pyrene labeled actin was prepared by diluting
100 mg of lyophilized pyrene actin into 2 mls of 5 mM Tris
(pH 8.0), 0.2 mM CaCl2, and 0.2 mM ATP (G-buffer) and
incubating for 1 hour at room temperature followed by an
additional hour of incubation at 4uC. Monomeric pyrene actin
was obtained by collecting the supernatant following a 2 hour,
100,000 rcf, 4uC spin in a Beckman Optima TLX Ultracentrifuge
using a TLA 55 rotor (Beckman Coulter Inc., Fullerton, CA).
Approximately 20 mg of pyrene labeled actin was gently mixed
with 5 mg of GST fusion proteins in a volume of 500 ml for
10 minutes prior to the addition of 1/20
th volume of polymeri-
zation buffer (500 mM KCl, 20mM MgCl2, and 10mM ATP).
The reaction was monitored over one hour with an LS 50B
Luminescence Spectrophotometer directed by FL WinLab
software version 4.0 (Perkin Elmer, Beaconsfield, BUCKS, UK)
with 2.5 nm bandwidth at 365 nm excitation wavelength and
2.5 nm bandwidth at 407 nm emission wavelength.
Peptide antibody delivery with Pro-Ject Protein
Transfection Reagent
Pro-Ject Protein Transfection Reagent was used according to
the manufactures instructions to deliver antibodies into host cells
(Pierce, Rockford IL). Briefly, 1610
5 HeLa cells grown on glass
coverslips were given 1mg of actin binding domain or Rickettsia
rickettsii specific antibodies premixed with transfection reagent for
3 hours. Cascade blue conjugated dextran was added to the
premixed transfection reagent to identify transfected cells by
immunofluorescence. Additional controls included delivery of
actin binding domain antisera neutralized with an excess of the
peptide immunogen and PBS alone control.
Invasion assay
C. trachomatis invasion of HeLa cells was determined essentially as
previously described using intrinsically fluorescent, CMPTX-
labeled C. trachomatis EBs [40]. Briefly, CellTracker (red) CMTPX
labeled C. trachomatis L2 EBs(MOI,50) werepermittedto attachto
antibody-loaded target cells for 30 min at 4uC. The cultures were
rinsed with cold HBSS and the temperature shifted to 37uC by the
addition of pre-warmed RPMI plus 10% FBS. The cultures were
then incubated at 37uC. The cultures were fixed with 4%
paraformaldehyde at room temperature for 15 min and rinsed
with PBS. The cells were not permeabilized. Extracellular EBs were
labeled for 1 hour with a monoclonal antibody specific for
chlamydial major outer membrane protein (MOMP). After four
washes in PBS, secondary antibody conjugated to Alexa 488 was
added for 1 hour. Coverslips were rinsed and mounted in ProLong
Gold antifade reagent (Invitrogen, Carlsbad, CA). Cells were
examined with a Nikon Microphot-FXA microscope equipped with
phase contrast and epifluorescence optics. Images were obtained
using a Photometrics CoolSnap HQ camera and processed using
Adobe Photoshop CS2. Percentage internalized was taken as total
EBs (red)2extracellular EBs (green)/total EBs (red)6100.
Gel filtration
TARP peptides suspended in 16PBS or buffer A were added to
a Superdex 200 10/300 GL gel filtration column (Amersham
Biosciences) controlled by a BioCAD Sprint Perfusion Chroma-
tography System (PerSeptive Biosystems Inc., Framingham, MA)
as previously described [14]. Eluted proteins were monitored by
A280 absorbance and peak fractions harboring eluted Tarp were
confirmed by immunoblot analysis.
Accession numbers
Accession numbers for Tarp orthologs used here are as follows:
C. trachomatis serovar L2, stain LGV434 - AAT47185, C. trachomatis
serovar D, strain UW3/Cx - NP 219969.1; C. trachomatis serovar A,
strain HAR-13 - YP328278.1; C. muridarum strain Nigg - NP
297115.1; C. caviae strain GPIC- NP 829043.1; C. pneumoniae strain
CWL029 - NP 224768.1.
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